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Abstract
The purpose of the present research was to assess the effects of essential oils derived
from the plant Lippia organoides on performance parameters, intestinal integrity, and necrotic
enteritis (NE) in broiler chickens. To do this, a previously established challenge model for NE
was utilized which included challenging with Salmonella Typhimurium on day 0, Eimeria
maxima on day 18, and Clostridium perfringens on days 22 and 23. Treatment groups included a
1) non-challenged, negative control, 2) challenged control, and 3) challenged, Lippia origanoides
(37ppm in the diet). Group 1 (negative control) had significantly (P < 0.05) higher body weight
gain from d8-25 and d0-25 compared to both challenged groups. Feed intake was significantly
different for all three groups (P < 0.05) at 8-25 days and 0-25 days with group 1 having the
highest feed intake for both time periods. Total mortality was greater in the positive control when
compared to both the negative and treatment groups. NE lesion scores were significantly
different between all groups with the positive control having the highest mean lesion scores and
the negative control having a mean lesion score of 0. The positive control group had the highest
FITC-d amounts detected in the sera, being statistically higher than both the treatment group and
negative group which were both statistically different from each other. At the present inclusion
rate for the essential oil (37 ppm), there was an overall reduction in the negative impact from the
NE infection. Further studies should be conducted to reach more significant conclusions.
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Chapter I. Thesis Introduction
For decades, antibiotic growth promoters (AGPs) have been used in poultry diets at
subtherapeutic dosages to improve performance (1). Consumer concern for antibiotic use, the
misuse of antibiotics, and multidrug resistance have caused a shift in the poultry industry. These
AGPs are being implemented less and less, leading to an uptick in the occurrence of many
bacterial diseases that were previously controlled by their use. Among the bacterial diseases on
the rise, is necrotic enteritis (NE). NE is caused by an over-proliferation of Clostridium
perfringens (CP), a Gram-positive, spore-forming bacterium in the gastrointestinal tract (GIT) of
broiler chickens and turkeys (2). There is evidence that suggests predisposing factors contribute
to the overgrowth of CP in the GIT (3). For instance, these predisposing factors directly change
the landscape of the GIT by damaging the lining of the intestines, promoting inflammation and
excessive mucin production. As a result, the composition and balance of the gut microbiota is
disrupted. Common predisposing factors for NE in broiler chickens include co-infection with
Eimeria maxima or dietary and environmental stressors (3).
Since antibiotic use is on the decline, there is a need for alternatives to mitigate NE in
commercial poultry flocks. The incidence of NE may be reduced by directly targeting the CP or
by indirectly controlling E. maxima cycling and limiting the use of dietary ingredients that
promote CP proliferation in the GIT. An antibiotic alternative currently of interest for use in
poultry diets is essential oils (EOs) and EOs derivatives. EOs are highly volatile compounds
extracted from aromatic plants (4). The natural compounds have been used for the treatment of
pain, inflammation, viral diseases and cancer in holistic medicine for centuries (5). As stated,
EOs are highly volatile, very unstable, and subject to degradation in their natural form. One way
to overcome this is to encapsulate the EOs in colloidal systems (6) or in polymer coatings and
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alginates (7) as the outer shell of the EO microencapsulation. Microencapsulation of the EOs
allows for easy and efficient mixing into different rations. Microencapsulation has also been
shown to create a slower and more targeted release of the product in the GIT (2).
In this study, EOs were derived from Lippa organoides plants and microencapsulated
through spray drying techniques. To replicate NE, broiler chicks were then exposed to
Salmonella Typhimurium at day-of-hatch and Eimeria maxima at day 18 to promote enteritic
inflammation and a damaged epithelial surface. These conditions provide an ideal environment
for CP replication and previous research has shown how Salmonella challenge during the
neonatal period followed by Eimeria maxima increases the NE-associated mortality (8). To
ensure uniform enteric colonization by CP, chickens were orally challenged with CP at day 22
and 23 days of age. Compared to the PC, EOs improved performance parameters, including body
weight at day 25 and body weight gain from day 0-25. However, there were no significant
differences in feed conversion ratio between the PC and EOs. At day 25, NE-associated lesion
scores in the group that received EOs in the diet at 37ppm were significantly (P < 0.05) lower
than the PC group. Additionally, inclusion of EOs markedly (P < 0.05) reduced CP recovery in
an in vitro digestion assay compared to the control. The impact of EOs on NE lesion scores and
CP proliferation in vitro suggest that the EOs have a negative effect on CP replication. There
were no differences in morbidity observed between the PC and EOs, but total mortality and NEassociated was significantly (P < 0.05) reduced in the EOs-treated group. The enzyme activity of
superoxide dismutase (SOD) was also measured. SOD acts on superoxide anions and breaks
them down into a hydrogen peroxide molecule and molecular oxygen (9). The PC had a
significantly (P < 0.05) lower SOD level than the treated group indicating that more superoxide
was being broken down, and not allowed to cause oxidative stress on the lining of the intestinal
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tract. Fluorescein isothiocyanate dextran (FITC-d) is a fairly large particle that cannot pass
through the GIT unless there is inflammation present. FITC-d is an established indicator for gut
leakage in poultry (10) In this study, PC serum FITC-d levels were found to be significantly
higher than the treatment group. This suggests that the PC had a higher rate of gut leakage and
gut inflammation than the treatment group. Interferon-gamma is important in the induction of
inflammation. They are produced by natural killer cells (11). Natural killer cells are part of the
innate immune system activated by several things including intracellular pathogens (12) such as
the predisposing factor for necrotic enteritis, Eimeria maxima. For this trial, the interferongamma levels found in serum were statistically higher in the PC group than in the treated group
suggesting that there was more inflammation in the GIT of the PC group. The PC also had
significantly higher levels of immunoglobulin-a (IgA) than the treatment group. IgA is an
indicator of mucosal production in the GIT (13). Therefore it can be supposed that there was
more mucus produced in the GIT of the PC group than in the treatment group.
From this trial, it can be concluded that L. organoides could be a viable alternative to
reduce the severity of NE in broiler chickens. Further research is recommended to investigate the
interaction of these EOs on Eimeria spp. and immunomodulatory effects on the host.
Sustainable, non-antibiotic alternatives are needed to prevent NE in commercial poultry flocks.
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Abstract
Due to the removal of antibiotic growth promoters (AGPs) and consumer pressure for
antibiotic-free (ABF) or no antibiotics ever (NAE) poultry production, there is a need for
sustainable alternatives to prevent disease in commercial poultry operations. Without AGPs, there
has been a rise in diseases that were traditionally controlled by subtherapeutic levels of antibiotics
in the diet. This has impacted the health of commercial poultry and has been a significant cost to
poultry producers. To mitigate this, the industry has started to investigate alternatives to antibiotics
to treat these forthcoming health issues, such as necrotic enteritis (NE). NE is an enteric disease
caused by an over proliferation of toxigenic Clostridium perfringens (CP) in the gastrointestinal
tract. Although CP is a commensal in the avian intestinal tract, dysbiosis caused by inflammation
and impaired intestinal integrity facilitates uncontrolled replication of CP. Infectious agents, such
as Eimeria maxima, appear to be a predominant predisposing factor that promotes NE. However,
non-infectious stressors, including dietary changes, have also been associated with NE to some
degree. As a result of increased pressure to restrict the use of antibiotics, there is a need for research
evaluating the efficacy of alternatives, such as plant-derived essential oils, as potential tools to
mitigate NE in commercial poultry flocks.
Introduction
Over the last few hundred years, Homo sapiens have dominated all known animal species
and altered every known ecosystem. This approach led to the genetic change of domestic animals
and was undoubtedly driven by agriculture. The most important genetic changes in domestic
animals occurred in the previous 60 years. Modern broiler chickens are likely the clearest example
of these genetic improvements. Newborn chicks grow 31 % (55 g/bird) on day one, and 5,902%
15

(2,521 g/bird) on day 35 (1). Intensive genetic selection, diet, health, and management initiatives
have led to these achievements. Nonetheless, maintaining the integrity of the gastrointestinal tract
(GIT), the primary organ responsible for digestion and nutritional absorption, is critical for
production. Because feed conversion accounts for over 70% of the cost of production in poultry
and animal enterprises, subclinical coccidiosis or necrotic enteritis in chickens is more costly than
acute infections (Figure 1). As the growing period of broilers shortens and feed efficiency
improves, so do health and nutrition programs. Because the changes during intestinal development
are microscopic, they are typically neglected—nevertheless, gut health influences overall health
and productivity.
Importance of GIT health in poultry
The GIT is home to a varied microbial community known as gut microbiota (2),
outnumbering somatic cells by tenfold, with 300,000 genes compared to 23,000 genes in chickens
(3, 4). The enteric nervous system (ENS) has approximately one hundred million neurons and is
referred to as the "second brain" of metazoans because of its importance in digestion (5).
Approximately 80 percent of the immune cells in the body are found in the gut-associated
lymphoid tissue (GALT). The Bursa of Fabricius, a lymphoid organ that is critical for Blymphocyte growth and proliferation in avian species, is a component of the GALT (6). As an
astonishment, the GALT comprises 80 percent of the plasma cells that are responsible for the
production of secretory immunoglobulin A (IgA), the far more prevalent immunoglobulin (7).
A range of physiological processes, including secretion, absorption, digestion, and gut motility,
are mediated by enteroendocrine cells (EECs), which also play a role in the etiology of intestinal
mucosa atrophy and malignancies, both within and beyond the GIT (8). Gastrin, secretin,
cholecystokinin, insulin, and glucagon were among the first GIT hormones to be discovered in
16

humans (9). The discovery of more than 50 gut hormones and bioactive peptides today confirms
that the gut is the body's largest endocrine organ, performing an extensive spectrum of
endocrinological, neuroendocrine, autocrine, and paracrine functions, as well as a variety of other
roles (10). Enterochromaffin cells, a subset of several EECs, produce 90% of the neurotransmitter
serotonin (5-hydroxytryptamine), which plays multiple biological roles in temperament,
perception, reproduction, vasodilation, gut motility, wound healing, and vasoconstriction (11).
Surprisingly, the gut microbiome modulates serotonin and other EEC-produced mood
neurotransmitters like dopamine, oxytocin, and endorphins (12-14). Published research have
shown that in humans, illnesses of the brain (such as schizophrenia, depression, Alzheimer's
disease, Parkinson's disease, and autism) are associated with the kind of microbiota prevalent in
the GIT (15, 16). The cliche "gut instincts" holds true in this case (17).
For more than a century, Eli Metchnikoff, the Nobel Prize-winning father of innate immunity,
offered the breakthrough idea of ingesting live bacteria to boost health by modifying the intestinal
microbiota (18, 19). Antibiotic resistance in bacteria (sometimes known as "superbugs") is a major
problem in medicine and agriculture around the world. As the number of antibiotic-resistant
bacteria grows, this concept is becoming increasingly relevant (20). According to recent research,
nutritional approaches may be effective alternatives to antibiotics in some cases (21-23). In
addition to increasing animal health, welfare, and production, boosting disease resistance in
antibiotic-free animals is an important task in enhancing food safety. Chronic inflammation in the
intestine is thought to be the root cause of 90% of all diseases (24). The gut microbiota influences
the host's biology, metabolism, nutrition, immunity, and neuroendocrine system (25, 26). Shortchain fatty acids, gastrointestinal hormones, enteroendocrine and immune cells all play a role in
these effects (27). The enteric nervous system and hormonal networks control GIT motility, which
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is impaired in functional GIT diseases (28). The neuroendocrine network that connects the brain,
the ENS, gut microbiota, and the GALT has a significant impact on the delicate intestinal epithelial
barrier (29, 30). This barrier, which consists of a single layer of enterocytes with tight intercellular
junctions, regulates the balance of tolerance and immunity to non-self antigens (31). Hence, gut
integrity is critical in maintaining a healthy balance of health and disease (32). To keep the system
in survival mode, chronic stress and chronic intestinal inflammation divert significant biological
resources away from development and reproduction. Perhaps a more comprehensive definition of
"gut health" should include the harmonious interaction of the microbiota-brain-gut axis (25, 33,
34).
All biological and physiological processes maintain the various microbiomes that live on mucosal
surfaces in balance (35). Dysbiosis (loss of symmetry of the GIT microbiota) leads to loss of
intestinal integrity (36). Dietary ingredients and the viscosity of gut contents influence microbes
in the small intestine (37). Animal producers who have eliminated antibiotics from their production
systems may use a combination of alternative products, improved management methods, stringent
biosecurity, and successful immunization programs to achieve their health and productivity goals.
However,

chronic stress and persistent inflammation still harm modern animal production

operations. Any source of chronic stress, whether biological, physical, chemical, toxic, or
psychological, will cause oxidative stress and, if unabated, chronic intestinal and systemic
inflammation (38-40). Chronic intestinal and systemic inflammation opens up the gut to
opportunistic bacteria such as C. perfringens.
Clostridium spp. in the GIT
To maintain gut homeostasis, a complicated mutualistic symbiosis maintains the hostmicrobiota connection (41). Commensal Clostridia (Class) in the Firmicutes (Phylum) make up a
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large proportion of the gut microbiota (42). Clostridial spp. begin colonizing the intestine at hatch,
live near intestinal cells, and play an important role in altering gut physiology and immunology
(42). Clostridium (Genus) contains over one hundred beneficial species, and only a few are
pathogenic (42). They represent the most significant butyric acid-producing organisms in the GIT
(43). Commensal Clostridia play an active role in maintaining overall gut function (42). Hence,
distinguishing beneficial Clostridial species from potentially virulent ones, like Clostridium
perfringens, is critical (44). Clostridial cluster IV contributes to up to twenty percent of bacteria
present in humans (45). Clostridium clusters XIVa and IV members consistently decreased in
patients with gut inflammation (46). This implies that these organisms are vital to gastrointestinal
homeostasis (44). Clostridiales (Order) also increased mucosal tolerance to commensal microbiota
by boosting IL-10 and transforming growth factor-beta expression levels in the gut (47).
Furthermore, Clostridiales such as Ruminococcus spp., Faecalibacterium spp., and
Lachnospiraceae spp. are the remarkable bacteria that produce butyrate (48, 49), inducing
profound physiological reactions in the gut (50). Clostridium cluster strains IV and XIVa are great
inducers of T-regulatory cells and constitute a novel therapeutic alternative for intestinal
inflammatory diseases (51). Interestingly, probiotics have been demonstrated to cause significant
alterations in butyrate and other key SCFA, which have a considerable impact on gut physiology
and immunology (52-57). Commensal Clostridium bacteria clearly are vital in gut homeostasis
(42). However, commensal Clostridial spp. such as C. perfringens rapidly proliferate when the
broiler’s epithelium is damaged (58). There are predisposing factors that increase C. perfringens
overgrowth such as nutritional components (59) and coinfections with Salmonella spp. (60) or
Eimeria spp. (61) (Figure 2). Mucin-2 is the most abundant mucin that is secreted by intestinal
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epithelial cells (62). Eimeria spp. have been shown to have an effect on the relative mucin secretion
in each area of the GIT (63).
Necrotic enteritis
Necrotic enteritis (NE) is caused by the ubiquitous bacterium C. perfringens. C.
perfringens is an anaerobic, gram-positive, endospore-forming, nonmotile, bacterium that can
survive and persist in harsh environmental conditions. As the chicken industry has reduced its
usage of antibiotics, NE in both its clinical and subclinical forms have become a significant health,
welfare, and performance problem (64). Because NE is a complex disease, that usually includes a
co-infection of Eimeria spp. and C. perfringens, management without antibiotics requires
sustainable alternative prophylactic or therapeutic strategies (65). The total global economic cost
of NE was assessed to be more than $2 billion dollars in 2000 (66). The number of broiler chickens
produced increased from 14.38 billion in 2000 to approximately 33 billion in 2020 worldwide (67).
It was estimated that necrotic enteritis cost the United States poultry industry $6 billion annually
(68).
C. perfringens is grouped into seven toxigenic categories (A−G) producing over twenty
toxins (69). The poultry industry is particularly interested in C. perfringens types A, C, and G (70,
71). In this process, C. perfringens releases enzymes that break down host tissue, causing more
tissue damage, inflammation, and disruption of the intestinal ecology, causing dysbiosis (72-74).
These avian C. perfringens strains produce pathogenic toxins including NetB toxin, which has
been identified as a major factor associated with NE in broilers (75). However, some strains can
cause NE without producing toxins (76), as proteolytic enzymes have also been identified to cause
severe damage to the enterocytes (77) (Figure 3). Field outbreaks of NE had one C. perfringens
clone prevalent in the intestines of all infected birds, rather than the variety of strains found in
20

healthy bird intestines. A single dominant C. perfringens strain associated with NE may be due to
bacteriocin production (78). Intestinal C. perfringens overgrowth has been linked to intestinal
mucosa injury, low pH, coccidiosis, nutritional factors, stress, and immunosuppression (75, 79,
80). Several investigators have evaluated different alternatives to reduce NE such as probiotics,
prebiotics, synbiotics, and organic acids (81-84).
C. perfringens infection alone is not enough to cause necrotic enteritis in broiler chickens.
Predisposing factors are a key player in creating the right environment for the proliferation of
virulent C. perfringens, producing disease (85). These predisposing factors can include, but are
not limited to, feed ingredients (86), coccidiosis caused by Eimeria spp. (87), environmental
stressors (88), and exposure to Salmonella spp. (60).
Alternatives to antibiotics to control NE
Due to the removal of AGPs and the shift to antibiotic free production systems, research
investigating antibiotic alternatives have been on the rise. The incidence of Clostridial-related
diseases, including NE, increased with implementation of AGP bans (89). In an antibiotic-limited
or antibiotic-free era, natural alternatives to optimize intestinal health and improve animal
wellbeing and performance are desperately needed. Probiotics are live, beneficial microorganisms
that have been shown reduce colonization by enteric pathogens (90-92). Direct-fed microbials
(93), prebiotics (94-96), organic acids (97), plant extracts (98), essential oils (99, 100), and trace
minerals (101) can help to improve intestinal microbial balance, metabolism, and gut integrity.
Phytogenics have remarkable antioxidant, anti-inflammatory, antibacterial, and barrier integrityenhancing assets. For example, supplementation with curcumin, a component in tumeric, reduced
the severity of necrotic enteritis (102), salmonellosis (98, 102), and aflatoxicosis (103) in broiler
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chickens as well as coccidiosis in Leghorn chickens (104). Additional investigations regarding
phytogenics, specifically EOs and gut health are described below.
Essential oils
Essential oils (EOs) are a derivative of plants. Revered for their medicinal properties, EOs
are natural, volatile compounds usually associated with a strong odor (105). EOs may consist of
over 50 single components, but the major components constitute ~85% of the EO and are the
primary components related to bacteriostatic or bactericidal activity (106). The mode of action(s)
of EOs has been extensively reviewed (107). EOs inhibit in vitro proliferation of Gram-negative
and Gram-positive bacteria by increasing membrane permeability of the cell wall and
mitochondrial membranes (107). Antimicrobial efficiency of EOs is impacted by the compound’s
hydrophobicity (108). In vitro studies show evidence that when compared to standard
antimicrobial agents, EOs have a similar effect on the growth inhibition of C. perfringens (109).
EOs have been increasingly popular as feed additives over the last two decades (110) due
to

their

antibacterial,

antiviral,

antifungal,

anti-inflammatory,

digestive

stimulant,

immunomodulatory, and anti-hyperlipidemic properties (111-114). Carvacrol and thymol are
abundant in plants, such as Lippia origanoides, and stimulate enzyme secretion and improve
digestion (115, 116) (Figure 4). Hence, EOs have been used as a feed additive in poultry diets
without adverse effects (117). However, one of the most remarkable bioactive properties of EOs
is their anti-oxidant effect, which prevents lipid peroxidation of the cell membrane and
mitochondrial membrane phospholipids, as well as the denaturalization of proteins and DNA,
thereby preventing multiple organ failure and other diseases (115, 116, 118,119).

22

At the moment of writing this paper, using the keywords “Essential oils and necrotic
enteritis” in Google scholar, the results show an astonishing number of scientific manuscripts:
8,720. Most studies involve using EOs instead of antibiotics to reduce the severity of NE,
demonstrating the bactericidal activity of EOs against C. perfringens (109, 120). Other recent
studies have revealed a reduction in NE-induced intestinal damage (61, 121-124), reduction in
mortality associated with NE (125, 126), regulation of the intestinal microbial communities (127129), modulation of short-chain fatty acids profiles (79, 130), improvement of the morphometric
and barrier functions (126, 131), as well as, reduction of oocyst counts

(132, 133) and

dysbacteriosis (134, 135). The impact of EOs on performance parameters and intestinal lesion
score in broiler chickens under different NE models has been summarized in Table 1.
EOs have been shown to alter the host’s immune response. Dietary inclusion of carvacrol,
cinnamaldehyde or oleoresin altered gene expression of intestinal intraepithelial lymphocytes,
with dietary oleoresin having the greatest effect on transcriptional regulation (136). Furthermore,
EOs limited pro-inflammatory cytokine production related to C. perfringens or Eimeria spp.
challenge (137). Pathogenicity of C. perfringens was modulated by the inclusion of EOs (25%
carvacrol, 25% thymol; 120mg/kg) in the diet which downregulated in vivo expression of C.
perfringens virulence factors: VF 0073-ClpE, VF0124-LPS, and VF0350-BSH (129). The altered
host ileal microbiome composition and C. perfringens virulence factor expression was likely
reduced intestinal lesion scores and mortality in broiler chickens (129). The direct or indirect
changes in the gut microbiome composition associated with EOs treatment is suggested to be a
primary beneficial factor related to application of EOs as natural alternatives to antibiotics.
Combinations of EOs and organic acids have synergistic or additive effects that may
improve poultry gut health and growth performance (138). Similar to dietary EOs fed alone, blends
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of EOs and organic acids alter the composition of the gut microbiota, specifically increasing the
abundance of Lactobacillus spp. (138) and SCFA concentration in the gut (139). As a result, the
dietary blends can inhibit the overgrowth of C. perfringens in the gut perhaps lowering the
incidence and severity of NE. For instance, encapsulated blends of EOs (thymol, vanillin, eugenol)
and organic acids (fumaric, sorbic, malic, citric) have been shown to improve gut health and
performance of NE-affected broiler chickens (140). Similarly, feeding microencapsulated blends
of EOs and organic acids (BUTYTEC-PLUS or ACITEC-MC) to broiler chickens placed on used
NE litter increased growth performance due to improved intestinal barrier function and integrity
(135). Enteric inflammation associated with NE may have been reduced due to the antiinflammatory effects of a dietary blend of encapsulated EOs and an organic acid (4% carvacrol,
4% thyme, 0.5% hexanoic, 3.5% benzoic, 0.5 % butyric acid) (131). Additionally, broiler chickens
that received the EO and organic acid blend had improved intestinal integrity compared to the nontreated, challenged group (131).
Taken together, phytogenic compounds, such as EOs show promise as natural alternatives
to mitigate the severity of NE-induced intestinal damage and performance losses. However,
factors including the antimicrobial activity of the specific EO evaluated, EO dose, NE challenge
model, and methods to determine efficacy of these naturally occurring AGP alternatives must be
considered when designing experiments and comparing research findings.
Brief overview of methods to evaluate impact of antibiotic alternatives on intestinal integrity
and enteric inflammation
Researchers could use enteric inflammation models to investigate alternative antibiotic
growth promoters (AGP) and dietary supplements for livestock, including poultry. As a result,
several intestinal inflammatory models including nutritional factors (37), management (141),
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chemicals(142, 143), and environmental influences (100) have been used to evaluate the effect of
AGP alternatives on enteric inflammation in a laboratory setting. A non-terminal approach, such
as serum fluorescein isothiocyanate-dextran (FITC-d) concentration, can be used to assess
intestinal permeability and tends to correlate with bacterial translocation in the liver (144). For the
FITC-d assay, a 4-6kDa FITC-d molecule is utilized since it cannot translocate through an
undamaged intestinal epithelium (145). Thus, an increase in FITC-d in the serum indicates that
there has been damage to the intestinal epithelial barrier (145). Other reliable serum biomarkers,
such as antioxidant biomarkers, isoprostane 8-iso-PGF2 and prostaglandin GF2, have been
evaluated (104). Enterocyte biomarkers such as peptide YY, Fenterocellular signal-regulated
kinase, citrulline, and mucin 2, as well as immune biomarkers peptide YY, enterocellular signalregulated kinase, citrulline, and mucin 2, total or specific secretory IgA and interferon-gamma
have been utilized (146, 147). IgA is closely associated with mucosal immunity in mammals and
avian species (148, 149). It is the main immunoglobulin isotype in most mucosal secretions (149).
Therefore, elevated IgA levels can be associated with elevated mucin production and an increased
immune response. Interferon-gamma is a pro-inflammatory cytokine associated with intestinal
inflammation and gut leakage (150). Thus, interferon-gamma levels in the serum can be used to
assess inflammation. Reactive oxygen species, such as superoxide are free radicals that are created
naturally through cellular respiration. Free radical accumulation is damaging (151). An enzyme,
superoxide dismutase catalyzes superoxide into oxygen and hydrogen peroxide (152). Superoxide
dismustase concentration in the sera has been used to assess oxidative stress in broiler chickens
(146). Additionally, gene expression of other biomarkers, such as 1-acid glycoprotein, fatty acidbinding protein, and interleukins (IL-8, IL-1β,), mucin 2, transforming growth factor, and tumor
necrosis factor have also yielded promising results (21, 153).
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Inflammation alters expression of intestinal tight junction proteins followed by increased
intestinal permeability (154). Futhermore, intestinal morphometric measurements, such as villus
height, villus width, crypt depth, and crypt/villi ratio can be used to evaluate gut integrity. An
increase in crypt depth and villus witdh was indicative of gut barrier failure in broiler chickens
(153). The I See Inside (ISI) methodology, which employs both macroscopic and histological
analyses, has been used to determine the impact of a treatment or challenge on an organs function.
This method been used to assess effect of EOs and organic acids on ISI scores in NE-challenged
broiler chickens (140).
Conclusion
The increased incidence of NE due to the removal of AGPs or shift to ABF or NAE
production in commercial poultry systems has been associated with reduced performance and
increased mortality (75, 155). C. perfringens is the causative agent for necrotic enteritis (156).
Biological and non-biological factors may increase predilection for NE in a flock. Biological
factors including Salmonella spp., E. maxima, or a diet change (60, 157). These predisposing
factors promote C. perfringens replication by disrupting the microbiota composition and damaging
the intestinal epithelial lining (85). Thus, NE can be consistently reproduced in a controlled
laboratory setting by challenging with Salmonella Typhimurium at placement, E. maxima at 18
days-of-age, and C. perfringens challenge at 22 and 23 days-of-age (60, 158). This challenge
model can be used to evaluate natural alternatives, such as plant-derived essential oils, to prevent
NE in broiler chickens, as confirmed by a recent study published in our laboratory (99).
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Table 1. Impact of essential oils (EOs) on performance parameters and intestinal lesion score in
broiler chickens under different necrotic enteritis (NE) models.
Essential oils /
Source

Dietary inclusion

Performance parameter

NE lesion score

References

Citrus, oregano and
annase EOs

1 g/kg of feed

Reduction in mortality (26% PC* vs
8% EOs).

1.33 vs 0.58 (PC
vs EOs).

(123)

Ginger oil and
carvacrol

1.5 g/kg of feed

EOs improve BW in 100 g
compared to the PC.

3.0 vs 2.3 (PC vs
EOs).

(159)

Capsicum oleoresin
and turmeric
oleoresin

4 mg of each
oleoresin per kg
of feed.

Improve BW (P < 0.05).

2.8 vs 1.2 (PC vs
EOs).

(160)

Thymol and
carvacrol

0, 60, 120 or 240
mg/kg of feed

EO linearly reduce FCR (P =
0.056).

1.5 vs <0.5 (PC vs
EOs).

(137)

Thymol and
carvacrol

120 mg/kg of feed

Reduction in mortality (20% PC vs
4% EOs).

>2 vs <1 (PC vs
EOs).

(138)

Thyme (thymol) and
clove (eugenol)

Combination:
Thyme 2.5 g/kg
and Clove 1.25
g/kg of feed

EOs improve BWG in 200 g
compared to PC.

3.0 vs 1.0 (PC vs
Eos).

(161)

Peppermint oil

0.5 or 0.25 ml/ml
of water

Reduction in mortality (55 % PC vs
10% EOs). Improve BWG in 41 g

Thymol and
carvacrol

120 mg/kg of feed

Reduction in mortality (20% PC vs
4% EOs).

>2 vs <1 (PC vs
EOs).

(125)

Garlic nanohydrogel

100, 200, 300 or
400 mg/kg

EOs increase BWG 181g, 367g and
588 g (200, 300 and 400 mg/kg).

>2 vs <1 (PC vs
400 mg/kg EOs).

(163)

Thyme, savory,
peppermint and black
pepper

0.5, 1 or 2 g/kg of
feed

Improvement in BW and FCR with
1 or 2 g/kg inclusion.

ND

(164)

Thymol and
carvacrol

200 or 300 mg/kg
of feed

Improve BWG during challenge
period (P < 0.05).

ND

(165)

Eugenol and garlic
tincture

100 mg/kg of feed

Overall FCR was improved 1.681
PC vs 1.645 EOs

0.5 vs <0.5 (PC vs
EOs – only in
males).

(132)

*

FCR 2.84 PC vs 1.88 EOs.

PC: Positive control; €ND: Not determined
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ND€

(162)

Figures

Figure 1. Even though necrotic enteritis is a multifactorial disease, Eimeria maxima has been
considered a primary pathogen in the clinical and subclinical outbreaks of necrotic enteritis. A)
Mucosal and submucosal jejunum with infiltration of inflammatory cells, ulceration, necrosis, and
the presence of E. maxima oocysts. Hematoxylin and eosin staining. NE causes macroscopic B)
ballooning of intestines and C) extensive sloughing of the intestinal mucosa and hemorrhaging. D)
While clinical and acute outbreaks can induce severe mortality, the global economic losses are due
to E) subclinical necrotic enteritis, affecting all performance parameters. (Created with
BioRender.com)
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Figure 2. A) Mucosal and submucosal jejunum with infiltration of inflammatory cells, ulceration,
necrosis, and the presence of E. maxima oocysts. Hematoxylin and eosin staining. B) Mucosal and
submucosal duodenum with infiltration of inflammatory cells, ulceration, necrosis and the
presence of Eimeria acervulina oocysts. Hematoxylin and eosin staining. C) Duodenum and
jejunum of a layer hen with necrotic enteritis. The liver shows areas of necrosis and hemorrhages
due to liver bacterial translocation and chronic systemic inflammation. D) Oviduct and ovary from
the same layer hen showing hemorrhages and inflammation. (Created with BioRender.com)
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Figure 3. C. perfringens types A, C, and G release A) enzymes that break down host tissue causing
B) inflammation, and disruption of the intestinal ecology, resulting in dysbiosis. NetB toxin, which
has been established as a significant contributor in NE in broilers, is present in these lethal avian
C. perfringens strains. Some strains, however, can produce NE without creating toxins, as
proteolytic enzymes have been shown to cause severe damage to enterocytes as a result of a severe
inflammatory response. C) Lesions caused by C. perfringens proliferation and toxin production
can be observed macroscopically. (Created with BioRender.com)
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Figure 4. Carvacrol and thymol are two of the most abundant essential oils present in A) Lippia
origanoides. Both essential oils have been extensively studied due to their B) anti-oxidant, C)
appetite stimulant and increased pancreatic enzyme production, D) immunoregulation, E) ability
to prevent hepatic damage, and F) anti-inflammatory properties. (Created with BioRender.com)
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Figure 7. Oxidative stress causes A) DNA damage and lipid peroxidation in vital cellular
components, such as B) the mitochondrial membrane and C) cell membrane. This triggers D)
apoptosis, necrosis, inflammation, and multiple organ failure. (Created with BioRender.com).
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Abstract
The objective of the present research was to evaluate dietary supplementation of essential
oils from Lippia origanoides (LEO) on necrotic enteritis (NE). At day-of-hatch, chicks were
randomly assigned to three groups. Group 1: negative control (NC); Group 2: positive control (PC)
challenged with Salmonella Typhimurium (day 1), Eimeria maxima (EM, day 18), and C.
perfringens (CP, days 22-23); Group 3: dietary supplementation with 37 ppm LEO, challenged in
the same manner as the PC. At the end of the trial, at d 25 of age, serum samples were collected to
evaluate FITC-d, SOD, IFN-γ, IgA. Chickens receiving LEO showed a significant improvement
in BW and BWG when compared with the positive challenge control chickens. Chickens that
received LEO had a significant improvement in FI compared with positive control chickens but
similar FCR. Digested feed was utilized for in vitro assays. The digested feed supernatant,
supplemented with LEO and inoculated with CP, showed a significant reduction in CP cfu/mL.
Treatment Group 3 also exhibited a significant reduction in NE lesion scores compared with
positive challenge control chickens. Chickens that received LEO showed a significant reduction
in FITC-d compared with positive challenge control chickens. A significant increase in serum
levels of SOD was also observed in chickens that received LEO compared with both control
groups. However, chickens receiving LEO showed a significant reduction in serum levels of IFNγ and IgA compared with positive control chickens. Further investigation to compare the effect of
LEO and the standard treatment of clostridial NE is required.
Introduction
In recent years, a considerable attention to essential oils (EO) as nutraceuticals in livestock
production has occurred, mainly as an alternative to antibiotic growth promoters (AGPs)
worldwide. Essential oils are derived from various plants as secondary metabolites with well50

documented antibacterial, antiviral, antifungal, antioxidant, digestive stimulants, and
immunomodulatory properties (1-5). Some EO are used in a combination with other
phytochemicals to increase performance in poultry (6). Hence, EO have played an important role
in controlling the increased incidence of coccidiosis and necrotic enteritis (NE) following the
removal of ionophores and AGPs. Since NE is a multifactorial disease involving Eimeria spp. and
C. perfringens, in many cases, EO are combined with other strategic products such as probiotics,
prebiotics, organic acids, and enzymes to modulate the intestinal microbiota and immune system
of the birds (7-9).
In poultry, NE is a disease caused by the anaerobe gram-positive bacterium, Clostridium
perfringens (CP). Several virulence factors have been identified in the pathogenesis of NE,
including toxins, proteolytic enzymes, bacteriocins, and adherent molecules produced by virulent
strains of CP (10). In 2000, the annual worldwide economic cost of NE was estimated at over $2
billion (11, 12). However, the global number of chickens has increased from 14.38 billion
chickens in 2000 to 23.70 billion chickens in 2018 (13). Based on those statistics, annual losses
associated with mortality and decreases in performance caused by NE at the end of 2020 can be
estimated at over $4 billion, especially in subclinical cases of NE (14,15). Several factors have
been identified in the pathogenesis of this multifactorial disease such as coccidia infections,
immunosuppression, dysbacteriosis, and removal of AGPs (7-10). Hence, several investigators
have evaluated the use of several nutraceuticals that include EO, organic acids, probiotics, and
plant extracts as an effort to reduce the economic impact that NE has in the modern poultry industry
(8,15-24).
After two years of unsuccessful attempts to reproduce a laboratory NE challenge model,
our laboratory inadvertently discovered the role of early Salmonella Typhimurium (ST) infection
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as a predisposing factor for NE (25). Our unexpected finding came after working with recombinant
Salmonella vaccine vectors containing Eimeria maxima (EM) epitopes (26). During those studies,
control chickens receiving the empty vector at day 1, but challenged with EM at day 18, showed
high mortality due to NE. Subsequent studies confirmed that day-old broiler chickens challenged
with ST, followed by EM and CP challenge at day 18, caused enhanced NE development compared
to an EM and CP challenge only (25). Puzzled by those results, we found that previous researchers
demonstrated severe immune suppression and injury to intestinal integrity by persistent local
inflammation caused by early ST infection in day-old chickens (27,28). Since then, we have used
ST as a neonatal infection to induce early immunosuppression for consistent and reliable NE
challenge in studies published by our laboratory (16,17, 29). The objective of the present research
was to evaluate dietary supplementation of Lippia origanoides essential oils (LEO) on in vitro
proliferation of C. perfringens, as well as performance, intestinal integrity, and NE lesions using
early Salmonella Typhimurium (ST) infection as a predisposing factor for NE in broiler chickens
(16, 17, 25, 29).
Materials and Methods
Essential oils from Lippia origanoides
The LEO was provided by Promitec S.A. (Bucaramanga, Santander, Colombia) and feed
inclusion based on the manufacturer's recommendations. The product contains EO of Lippia
origanoides microencapsulated with maltodextrin by spray drying with a diet inclusion rate of 37
ppm. Starter, grower, and finisher diets used in this experiment were formulated to approximate
the nutritional requirements of broiler chickens as recommended by the National Research Council
(30) and adjusted to the breeder’s recommendations (31). No antibiotics, coccidiostats or enzymes
were added to the feed (Table 1).
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Ethics
This study was carried out in accordance with the recommendations of the Institutional
Animal Care and Use Committee (IACUC) at the University of Arkansas, Fayetteville, under
protocol #21018.
Experimental design
In the present study, an experiment was conducted to evaluate the effect of L. origanoides
LEO on a NE model previously described by our laboratory (25), which was confirmed and
extended in more recent studies (16, 17, 29). Day-of-hatch Cobb 500 male broiler chicks (n= 300)
were obtained from a commercial hatchery. At day-of-hatch, chicks were randomly assigned to
one of three groups, with ten replicates and ten chickens in each replicate (n=10 replicates/group;
10 chickens/replicate). Group 1: negative control (NC); Group 2: positive control (PC) challenged
with Salmonella Typhimurium (day 1), E. maxima (day 18), and Clostridium perfringens (days 22
and 23); and Group 3: 37 ppm final feed concentration LEO, challenged in the same manner as the
PC
Body weight was recorded on days 0, 7, 14, 18, and 25. Body weight gain was recorded on
d 0-7, 8-25, and 0-25. Feed intake (FI) and feed conversion ratio (FCR) per cage were recorded on
d 0-7, 8-25, and 0-25.
Evaluation of serum levels of FITC-d, SOD, IFN- γ, and IgA
At the end of the trial, on d 25 of age, two random chickens per cage were selected (n=20)
and orally gavaged with 8.32 mg/kg of body weight of fluorescein isothiocyanate-dextran (FITCd, MW 3-5 KDa; Sigma-Aldrich Co). One hour after FITC-d administration, chickens were
euthanized by CO2 inhalation. Blood samples were collected from the femoral vein and centrifuged
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(1000×g for 30 min) to separate the serum. Serum levels of FITC-d (ng/mL) were used as a
biomarker to evaluate intestinal permeability as described by Baxter et al. (32). Commercial kits
were used to evaluate serum levels of superoxide dismutase (SOD, U/mL), gamma interferon
(IFN-γ, pg/mL), and immunoglobulin A (IgA, ng/mL) as described by (33).
Necrotic enteritis lesion score
Ileal NE lesion score (n=40 chickens/group) was evaluated as previously described (34)
where 0 = no lesions; 1 = thin-walled and friable intestines; 2 = focal necrosis, gas production, and
ulceration; 3 = extensive necrosis, hemorrhage, and gas-filled intestines; and 4 = generalized
necrosis typical of field cases and marked hemorrhage.
Necrotic enteritis model: challenge organisms
The Salmonella Typhimurium (ST), E. maxima Guelph strain (EM- GS), and Clostridium
perfringens (CP) isolate details and culture conditions used to induce NE are described in previous
studies (16, 17, 25, 29, 35). One-day-old broiler chickens were weighed and challenged with 1x108
cfu of ST per bird by oral gavage. At day 18, chickens in challenged groups were orally gavage
with 40,000 oocyst per mL. The dose was selected based on a prvious trial conducted to determine
a challenge dose causing sub-clinical coccidiosis and reduction of 35 % body weight gain as
described previously (16, 17, 25, 29). The C. perfringens culture was administered on days 22 and
23 of age via oral gavage at a concentration of 1 x 109 cfu per bird and was also used in the in vitro
proliferation assay (described below).
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Clostridium perfringens proliferation using in vitro digestion assay
The in vitro digestion model used in this trial was centered on earlier studies (35, 36. The
test was conducted using digested diets of the starter control feed or the control starter feed
supplemented with LEO (37 ppm). An inoculum of 105 cfu/mL of CP was included to five
replicates (n=5) in two groups containing: Group 1) 3mL TSB supplemented with THIO + 3 mL
supernatant from digested control diet (positive control); or Group 2) 3mL TSB supplemented with
THIO + 3mL supernatant from a digested diet supplemented with LEO. Supernatant from digested
control diet without C. perfringens inoculation was included as a negative control group. Samples
were incubated anaerobically at 40°C, with tubes set at a 30° angle with continuous shaking (200
rpm) for four hours. Following incubation, ten-fold serial dilutions were made from all three
experimental groups, plated on TSA supplemented with THIO and incubated for twenty-four hours
at 40°C, anaerobically. Results are reported as log10 cfu of CP per mL.
Data and statistical analysis
All data were subjected to analysis of variance as a completely randomized design, using
the General Linear Models procedure of SAS (37). Significant differences among the means were
determined by Duncan's multiple range test at P < 0.05.
Results
Effect of LEO on growth performance of chicken challenged with NE organisms
The evaluation of body weight, body weight gain, feed intake, and feed conversion ratio in
broiler chickens consuming a diet supplemented with 37 ppm LEO on a necrotic enteritis challenge
model are summarized in Table 2. Chickens that were challenged with ST at d 1 showed a
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significant reduction (P < 0.05) in BW at d 7 when compared with negative control chickens. It
was interesting to observe that chickens that received the diets with the inclusion of LEO had a
similar BW compared with negative control chickens on d 14 and 18, before E. maxima challenge.
At the end of the trial, chickens receiving LEO showed a significant improvement in BW and
BWG when compared with the positive challenge control chickens (Table 2). As expected,
negative control chickens showed a significant increase in FI and more efficient FCR as compared
with chickens that were challenged. In this study, chickens that received LEO had a significant
improvement in FI compared with positive control chickens but similar FCR (Table 2).
Improvement of intestinal integrity, antioxidant, and anti-inflammatory effect of LEO in
chicken challenged with NE organisms
Figure 1 shows the results of the serum FITC-d levels, SOD, IFN-γ, and IgA in broiler
chickens consuming a diet supplemented with 37 ppm LEO on a necrotic enteritis model challenge
model. A significant reduction in FITC-d serum levels was observed in chickens in the negative
control group when compared with chickens that were challenged. Interestingly, chickens that
received LEO showed a significant reduction in leakage of FITC-d from the intestine into the
bloodstream when compared with positive challenge controls (Fig. 1A). Furthermore, a significant
increase in serum levels of SOD was also observed in chickens that received LEO compared with
both control groups (Fig. 1B). Interestingly, chickens receiving LEO showed a significant
reduction in serum levels of IFN-γ and IgA compared with positive control chickens (Fig. 1C and
Fig. 1D).

56

Antimicrobial effect of LEO on Clostridium perfringens log10 count using in-vitro digestion
assay
The supernatant from digested feed supplemented with LEO and inoculated with CP
showed a significant reduction in log10 cfu/mL of CP when compared with the positive control
feed without LEO Supernatant from digested feed without CP inoculation remain negative to
CP (Table 3).
Protective effect of LEO against NE lesion in chickens challenged with NE organisms
Chickens that consumed LEO -supplemented feed had a significant reduction in NE lesion
scores compared with positive challenge control chickens. No lesions were observed in negative
controls (Table 3).
Discussion
It is estimated that EO are produced by over 17,500 species of plants; however, only a
minor fraction are used commercially (38). The chemical composition of EO include several
terpenes, terpenoids, and phenylpropanoids. Additionally, sulfur derivatives, fatty acids,
aldehydes, alcohols, and oxides have also been identified (39, 40).
Due to their antimicrobial properties, the use of whole EO are more advantageous than
purified components due to synergistic effects, multiple biological properties, and fewer
probabilities to select for antimicrobial resistance (38, 40, 41, 42 ). One particular study has
emphasized the antimicrobial effects of essential oils, even against multi-drug resistant bacteria
(43). In another recent study, flow cytometry showed EO's antimicrobial properties are due to the
increase in the permeability of the bacterial membrane and inhibition of the efflux pump activity
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(44). In the same study, the immunomodulatory effect of EO on THP-1 cells was also demonstrated
by gene expression profiles of pro-and anti-inflammatory cytokines (44). Of equal importance, EO
biological properties have been associated with maintaining intestinal integrity, strengthening the
mucosal barrier, and microbiota modulation (1, 4-6, 8, 18, 19).
Even at low concentrations, EO have shown substantial and superior antibacterial
properties against C. perfringens and other pathogenic bacteria compared to antibiotics (45).
Similarly, in the present study, feed inclusion of 37 ppm LEO significantly reduced the
proliferation of C. perfringens in the digested supernatant of an in vitro digestive model compared
to the positive control diet by 1.94 logs (Table 3). While EO have shown enhanced antimicrobial
activity, the encapsulation of EO has shown higher antimicrobial activity compared to the use of
EO alone by slowing down the degradation and reducing the organoleptic effects of EO (46, 47).
In the present study, LEO was microencapsulated with maltodextrin through the spray dry process.
At an inclusion rate of 37 ppm, this formulation showed a significant improvement in BW and a
significant reduction in NE lesion scores compared with the positive challenge control group
(Table 2 and Table 3). These findings are in agreement with the results published by other studies
(20-24). Moreover, chickens that received LEO had a significant decrease in FITC-d serum levels
compared to positive challenge control chickens (Table 3). Due to its high molecular weight (3-5
KDa), intestinal leakage of FITC-d has been reported to be a reliable biomarker to evaluate
intestinal inflammation and disruption of tight junction proteins in several poultry models
published by our laboratory (48-52). Other investigators showing a substantial improvement on
intestinal integrity and permeability by oregano EO (53, 54) have described similar results.
Furthermore, there was a significant reduction in IFN-γ serum levels in chickens that
received LEO compared with positive control chickens, suggesting a reduction in the inflammatory
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response (33, 55, 56). Moreover, these serological results were also associated with a significant
reduction in secretory IgA serum levels in chickens supplemented with LEO compared with the
positive control (Table 3). Comparable results have been confirmed in previous studies conducted
in our laboratory with the use of other phytobiotics, organic acids, and probiotics (16, 57, 58). As
indicated by Staley et al. (59), secretory IgA is an excellent biomarker to evaluate stress and
inflammation.
In addition to their antimicrobial properties, other assets of EO are their antioxidant activity
and radical scavenging activities (60). In the present study, chickens fed the formulation of
microencapsulated LEO at 37 ppm had increased SOD serum concentrations compared with the
positive control chickens (Table 3). Free radical scavenging capacity protects the integrity of
cellular and mitochondrial membranes from lipid peroxidation (61, 62). The EO from L.
origanoides have shown to increase the antioxidant response, radical scavenging activity, and
apoptosis, suggesting a unique mechanism by these compounds (63-68).
Conclusions
In summary, the results of the present study are not new or novel. Rather, confirm what it
has been published by multiple research groups describing the role of EO and other nutraceuticals
as alternative tools to reduce the severity of NE (8, 15-24). Hence, in the present study, the
antimicrobial, anti-inflammatory, and antioxidant properties of LEO were associated with
improved performance and reduction of lesion scores compared to challenged control chickens in
a NE model that includes an ST infection as a predisposing factor for NE in broiler chickens (16,
17, 25, 29). However, further investigation to compare the effect of LEO and the standard
treatment of clostridial NE is required. It is fair to mention that this was a limitation in the present
59

study. Moreover, it is imperative to establish standardized protocols that consider individual and
inter-sample variability and consider the utility of molecular tools and epigenetic adjustments
underlying phytobiotics such as EO, where research has not yet been elucidated.
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Tables
Table 1. Ingredient composition and nutrient content of the corn-soybean diet used on an as-is
basis
Stater phase
Grower phase
Finisher phase
Item
(d 1 to 7)
(d 8 to 14)
(d 15 to 25)
Ingredients (%)
Corn 9-14-18
SBM (45.16%)
DDGS 8.1% EE
Poultry fat
Limestone
Dicalcium phosphate
Salt
DL-methionine
L-lysine HCl
Waldroup TM Mix
Tyson 2x Broiler Vit
L-threonine
Choline chloride (60%)
Sodium bicarbonate
OptiPhos2000 (0.5lb/ton)
Se Premix (0.06%)
Santoquin
Total
Calculated analysis
ME (kcal/ kg)
Ether extract (%)
Crude protein (%)
Lysine (%)
Methionine (%)
Threonine (%)
Tryptophan (%)
Total calcium (%)
Total phosphorus (%)
Available phosphorus (%)
Sodium (%)
Potassium (%)
Chloride (%)
Magnesium (%)
Copper (%)
Selenium (%)
Linoleic acid (%)

51.80
37.66
4.00
3.24
1.08
1.01
0.35
0.29
0.12
0.10
0.10
0.08
0.06
0.04
0.025
0.020
0.019
100

57.81
31.62
4.00
3.44
1.06
0.88
0.35
0.25
0.13
0.10
0.10
0.09
0.06
0.05
0.025
0.020
0.019
100

59.64
27.23
6.00
4.38
1.03
0.64
0.31
0.22
0.12
0.10
0.10
0.09
0.05
0.03
0.025
0.020
0.019
100

3015.00
5.88
22.30
1.18
0.59
0.77
0.25
0.90
0.63
0.45
0.20
1.06
0.27
0.19
19.20
0.28
1.01

3090.00
6.20
20.00
1.05
0.53
0.69
0.22
0.84
0.58
0.42
0.20
0.94
0.28
0.18
18.46
0.27
1.13

3175.00
7.28
18.70
0.95
0.48
0.65
0.20
0.76
0.53
0.38
0.18
0.87
0.25
0.17
18.85
0.26
1.16
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Table 2. Evaluation of body weight (BW), body weight gain (BWG), feed intake (FI), and feed
conversion ratio (FCR) in broiler chickens consuming a diet supplemented with 37-ppm Lippia
origanoides essential oils on a necrotic enteritis challenge model*
Item
BW, g/broiler
d0
d7
d 14
d 18
d 25
BWG, g/broiler
d 0-7
d 8-25
d 0-25
FI, g/broiler
d 0-7
d 8-25
d 0-25
FCR
d 0-7
d 8-25
d 0-25

Negative Control

Positive Control*

Lippia origanoides*

42.24 ± 0.36 a
156.08 ± 3.03 a
445.35 ± 8.98 a
690.13 ± 10.02 ab
1185.53 ± 12.80 a

41.87 ± 0.34 a
140.84 ± 1.96 b
415.24 ± 6.02 b
659.58 ± 8.18 b
828.82 ± 9.80 c

42.73 ± 0.30 a
147.50 ± 4.8 2ab
436.93 ± 9.71ab
690.84 ± 12.0 5ab
862.49 ± 13.39 b

113.83 ± 3.14 a
1000.12 ± 12.6 a
1135.09 ± 12.86 a

98.97 ± 1.85 c
653.45 ± 10.77 b
776.62 ± 10.16 c

104.77 ± 4.68 ab
649.07 ± 17.20 b
800.44 ± 13.62 b

142.91 ± 10.07a
1180.75 ± 31.01a
1537.38 ± 20.30a

132.93 ± 2.58a
983.39 ± 23.74b
1295.70 ± 24.99c

131.41 ± 3.10a
901.94 ± 20.94c
1373.92 ± 64.61b

1.25 ± 0.07a
1.37 ± 0.03c
1.36 ± 0.02c

1.35 ± 0.03a
1.73 ± 0.04b
1.67 ± 0.04b

1.28 ± 0.07a
1.87 ± 0.11a
1.75 ± 0.08a

*Day-old broilers were challenged with Salmonella Typhimurium (day 1), E. maxima (day 18),
and Clostridium perfringens (days 22 and 23).
Data are expressed as mean ± SE.
significant difference at P < 0.05.

a,b,c

Non-matching superscripts within rows indicates

Table 3. Evaluation of Clostridium perfringens proliferation using in vitro digestion assay and
necrotic enteritis (NE) lesion scores in broiler chickens supplemented with Lippia origanoides
essential oils on a necrotic enteritis model challenge model
Item

Negative Control

Positive Control

Lippia
origanoides

C. perfringens (log10 cfu/mL)

0.00 ± 0.00 c

6.95 ± 0.20 a

5.01 ± 0.10 b

NE Lesion scores

0.00 ± 0.00 c

2.63 ± 0.05 a

1.76 ± 0.11 b

Data are expressed as mean ± SE.
a,b,c
Non-matching superscripts within rows indicates significant difference at P < 0.05.

70

Figures
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Figure 1. Evaluation of serum levels of fluorescein isothiocyanate dextran (FITC-d), superoxide
dismutase (SOD), gamma interferon (IFN-γ), and IgA in broiler chickens supplemented with
Lippia origanoides essential oils on a necrotic enteritis model challenge model. A) FITC-d, B)
SOD, C) IFN-γ, and D) IgA. a,b,c Non-matching superscripts indicates significant difference at P
< 0.05.
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Chapter IV. Conclusion
There is still much to be learned about essential oils and their effect on the
gastrointestinal tract (GIT) of poultry. In this study, the essential oil from Lippia origanoides
(LEO) was seen to reduce necrotic enteritis lesions when compared to the positive control. It was
also shown that the dietary inclusion of the essential oil improved all the performance parameters
in comparison to the challenged untreated group. Additionally, administration of LEO reduced
intestinal permeability and inflammation, as well as, enhanced the antioxidant activity in the
supplemented animals. Moreover, when using an in vitro digestion model, it was also observed
that LEO decreased the proliferation of Clostridium perfringens, further supporting the results
observed during the in vivo study. These kind of results have been published multiple times by
different research groups, all suggesting a reduction in necrotic enteritis lesions with no negative
effects on bird performance. More research should be conducted comparing the LEO to the
current standard treatment of clostridial necrotic enteritis. These results also validate the necrotic
enteritis challenge model used in this trial. The Salmonella challenge on day of hatch predisposes
the GIT to the Eimeria challenge on day 18. Both of the challenges set up the GIT for the
opportunistic bacteria, C. perfringens, to colonize and induce necrotic enteritis. In the end, the
inclusion of essential oils has the potential to be a reliable alternative to the use of antibiotics that
the poultry industry can utilize to maintain production standards and a positive economic impact.
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